“Lighten This Burden of Ours”: Acceptability and Preferences Regarding Injectable Antiretroviral Treatment Among Adults and Youth Living With HIV in Coastal Kenya

Author:

Simoni Jane M.123ORCID,Beima-Sofie Kristin2,Wanje George4,Mohamed Zahra H.2,Tapia Kenneth2,McClelland R. Scott2456,Ho Rodney J. Y.78,Collier Ann C.5,Graham Susan M.256ORCID

Affiliation:

1. Department of Psychology, University of Washington, Seattle Washington, USA

2. Department of Global Health, University of Washington, Seattle Washington, USA

3. Department of Gender, Women and Sexuality Studies, University of Washington, Seattle Washington, USA

4. Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya

5. Department of Medicine, University of Washington, Seattle Washington, USA

6. Department of Epidemiology, University of Washington, Seattle Washington, USA

7. Department of Pharmaceutics, University of Washington, Seattle Washington, USA

8. Department of Bioengineering, University of Washington, Seattle Washington, USA

Abstract

Background: Long-acting injectable (LAI) antiretroviral therapy (ART) may offer persons living with HIV (PLWH) an attractive alternative to pill-based treatment options, yet acceptability data remain scant, especially in sub-Saharan Africa. Methods: We conducted 6 focus group discussions with PLWH, including key stake holder groups, and analyzed data with content analysis. Results: Initial reactions to the idea of LAI-ART were often positive. The primary advantages voiced were potential to facilitate improved adherence and alleviate the burden of daily pill-taking while avoiding inadvertent disclosure and HIV stigma. Potential side effects were a particular concern of the women. Most participants preferred clinic-based administration over self-injections at home due to concerns about safety, privacy, and potential need for refrigeration. Conclusions: LAI-ART may be acceptable in Kenya, provided injections are infrequent and delivered in a clinic setting. However, HIV stigma, fear of potential side effects, and limited clinical capacity would need to be addressed.

Funder

National Institute of Allergy and Infectious Diseases

Publisher

SAGE Publications

Subject

Infectious Diseases,Dermatology,Immunology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3